These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 677865)

  • 1. Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies.
    Gray BM; Hubbell CA; Dillon HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):988-91. PubMed ID: 677865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC; Gray BM; Ware JC
    Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffusion disk susceptibility testing with cefaclor.
    Shadomy S; Carver M
    Antimicrob Agents Chemother; 1978 Feb; 13(2):228-33. PubMed ID: 646345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
    Nannini EC; Stryjewski ME; Singh KV; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2010 May; 54(5):2206-8. PubMed ID: 20211890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies with cefaclor, a new oral cephalosporin.
    Sanders C
    Antimicrob Agents Chemother; 1977 Oct; 12(4):490-7. PubMed ID: 921244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies on cefprozil granules in pediatric skin soft tissues infections].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Tanaka K; Matsukuma Y
    Jpn J Antibiot; 1992 Dec; 45(12):1684-99. PubMed ID: 1289588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin.
    Mayhall CG; Medoff G; Marr JJ
    Antimicrob Agents Chemother; 1976 Oct; 10(4):707-12. PubMed ID: 984804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
    Bianchi P; Frongillo RF
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):488-95. PubMed ID: 6255966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
    Preston DA; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of three cephalosporins against Staphylococcus aureus isolated from bovine mastitis.
    Lopes CA; Moreno G
    Res Vet Sci; 1991 Nov; 51(3):339-40. PubMed ID: 1780593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
    Antimicrob Agents Chemother; 1980 May; 17(5):856-60. PubMed ID: 6901595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins.
    Laverdiere M; Welter D; Sabath LD
    Antimicrob Agents Chemother; 1978 Apr; 13(4):669-75. PubMed ID: 352261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
    Miraglia GJ; Renz KJ; Gadebusch HH
    Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.